Skip to content
TirzepatideReport

Tirzepatide monograph · Evidence review

BioGlow Health Tirzepatide Review: Cost & Honest Verdict (2026)

An honest 2026 review of BioGlow Health tirzepatide — a multi-vertical telehealth platform, on a site that renders no content statically.

Researched & written by Alan Pierce · last updated

Clinical Pharmacology Writer

On this page

Editorial pick

CoreAge Rx

$149/mo flat

Doctor-reviewed tirzepatide with one flat price and built-in human support.

Advertising disclosure · we may earn a commission at no extra cost to you.

Check availability
vs median
$120/mo below the $269 median
Market
$109–$429/mo across 396 providers
Dispensed
Compounded tirzepatide (503A)

Popular alternative

Strut Health

Injectable or sublingual tirzepatide at the same $199, for anyone who would rather not inject at all.

$149/mo injectable

FDA warning letter
FDA issued Strut Health, LLC dba Strut a warning letter in February 2026 (False & Misleading Claims/Misbranded (Telehealth)). Read the letter on FDA’s own warning-letter database.

Check Strut Health availability

This review attempted to independently verify BioGlow Health directly against bioglowhealth.io and could not: the site is a client-side-rendered single-page app whose static HTML carries only a title and meta description, no actual page content. Everything below is rather than a live reconfirmation.

Live verification was limited

This review attempted to independently confirm BioGlow Health's current pricing and program details directly against bioglowhealth.io. The page loaded, but its static HTML renders only a title and meta description — the actual content is built client-side in JavaScript, the same rendering pattern that has blocked static verification on other providers reviewed on this site. Every figure below was last verified on June 7, 2026. Visit bioglowhealth.io directly to confirm current terms before committing.

§ BioGlow Health — What Live Verification Found

ItemStatus
Live verificationLimited — client-side-rendered SPA, no static content
Tirzepatide price$169/mo
Also sellsRetatrutide, an FDA-unapproved investigational molecule
This review's live pass found only a client-side-rendered shell; every fact here is from 2026-06-07.

What BioGlow Health is

BioGlow Health is a physician-supervised, multi-vertical telehealth brand, covering weight loss, peptides, testosterone, ED, and hair — not a weight-loss specialist. It ships compounded medication to all 50 states with a free consultation and free shipping, and requires a physician-supervised intake before any prescription.

What BioGlow Health costs

Compounded tirzepatide runs $169/month, with compounded semaglutide starting somewhat higher than most competitors in this category. BioGlow Health also sells retatrutide, an investigational molecule the FDA has not approved for any indication — worth knowing regardless of which product you're considering.

The brand-vs-compounded question

BioGlow Health dispenses compounded tirzepatide, not the FDA-approved branded product. Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug, and was not the specific product studied in the pivotal trials. See our guide to whether compounded tirzepatide is still legal in 2026 for the regulatory picture.

How the care model holds up

BioGlow Health's real strengths is a free consultation and free shipping nationwide, coverage across all 50 states, and a physician-supervised intake before any prescription. The trade-offs are notable: premium pricing relative to most competitors, an investigational molecule (retatrutide) sold alongside FDA-recognized GLP-1s, prescribing clinicians and the compounding pharmacy partner aren't named, it's cash-pay only with no insurance accepted, and the operating entity and credentials are lightly disclosed. This review's own attempt to verify any of it live was also blocked by the site's client-side rendering. As with any GLP-1 program, and especially one this thin on public disclosure, confirm every detail directly before committing; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-11, and better than semaglutide head-to-head2 — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

BioGlow Health's free consultation and nationwide shipping are genuine positives but this review couldn't independently verify any of it live, and the combination of premium pricing, an unapproved investigational molecule on the same menu, and unnamed clinicians and pharmacy warrants real caution. Ask directly before committing. For a similarly multi-vertical platform this review could independently verify live, compare BiltRx; for a provider that names its compounding pharmacy, see BetterMe Rx. Another rate-limited provider handled with the same honesty standard is Bodi Envi. See our best tirzepatide providers ranking for the full field.

Frequently asked questions

How much does tirzepatide cost through BioGlow Health?

$169/month. This review could not independently reconfirm this live — bioglowhealth.io renders its content client-side in JavaScript, leaving no static text to verify.

Does BioGlow Health sell retatrutide?

Yes — an investigational molecule the FDA has not approved for any indication, sold alongside its GLP-1 offerings.

Does BioGlow Health name its compounding pharmacy?

No — prescribing clinicians and the compounding pharmacy partner are not named publicly.

References(2)

  1. Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A, and the SURMOUNT-1 Investigators (2022). Tirzepatide Once Weekly for the Treatment of Obesity.. New England Journal of Medicine. PMID: 35658024. https://pubmed.ncbi.nlm.nih.gov/35658024/
  2. Aronne LJ, Horn DB, le Roux CW, Ho W, Falcon BL, Bays HE, et al. (2025). Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5).. New England Journal of Medicine. PMID: 40353578. https://pubmed.ncbi.nlm.nih.gov/40353578/

About the author

Alan Pierce

Clinical Pharmacology Writer

About Tirzepatide Report · How we verify prices · This page last updated August 2026

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.